Results
|
1.
|
Characterization of salivary gland side effects secondary to 131I therapy: final report of the thyroid cancer survivors' association, inc. (ThyCa) national survey for intermediate and long term results MedStar authors:
- Hall, Jordan
- Khorjekar, Gauri
- Mete, Mihriye
- Orquiza, Michael D
- Van Nostrand, Douglas
Year: 2013
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Department: - Medicine/Nuclear Medicine
All authors: - Orquiza M, Hall J, Van Nostrand D, Khorjekar G, Brennan M, McIver B, Mete M, Bloom G
|
|
2.
|
Metformin attenuates 131I - induced decrease in peripheral blood cells in patients with differentiated thyroid cancer MedStar authors:
- Bikas, A
- Burman, Kenneth D
- Desale, Sameer
- Mete, Mihriye
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2015
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
- MedStar Washington Hospital Center
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bikas A, Van Nostrand D, Jensen K, Desale S, Mete M, Wartofsky L, Vasko V, Burman K
|
|
3.
|
Metformin attenuates 131I - induced decrease in peripheral blood cells in patients with differentiated thyroid cancer MedStar authors:
- Bikas, A
- Burman, Kenneth D
- Desale, Sameer
- Mete, Mihriye
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2015
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
- MedStar Washington Hospital Center
Department:
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
All authors: - Bikas A, Van Nostrand D, Jensen K, Desale S, Mete M, Wartofsky L, Vasko V, Burman K
|
|
4.
|
Effects of dosimetry-guided 131I therapy for metastatic differentiated thyroid cancer on complete blood counts MedStar authors:
- Bikas, A
- Burman, Kenneth D
- Desale, Sameer
- Mete, Mihriye
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2014
Institution:
- MedStar Health Research Institute
- MedStar Heart & Vascular Institute
- MedStar Washington Hospital Center
All authors: - Bikas A, Burman K, Desale S, Mete M, Wartofsky L, Van Nostrand D
|
|
5.
|
Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for Metastatic Differentiated Thyroid Cancer (DTC). MedStar authors:
- Atkins, Frank
- Garcia, Carlos
- Khorjekar, Gauri
- Mete, Mihriye
- Orquiza, Michael D
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2013
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Department: - Medicine/Nuclear Medicine
All authors: - Khorjekar G, Orquiza MD, Atkins F, Mete M, Garcia C, Wartofsky L, Van Nostrand D
|
|
6.
|
Correlation of 124 I PET dosimetry with clinical response of 131 I therapy for metastatic differentiated thyroid cancer. MedStar authors:
- Atkins, Frank
- Garcia, Carlos
- Khorjekar, Gauri
- Mete, Mihriye
- Orquiza, Michael D
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2013
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Department: - Medicine/Nuclear Medicine
All authors: - Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D
|
|
7.
|
Correlation of 124I PET dosimetry with clinical response of 131I therapy (Tx) for metastatic differentiated thyroid cancer (DTC) MedStar authors:
- Atkins, Frank
- Garcia, Carlos
- Khorjekar, Gauri
- Mete, Mihriye
- Orquiza, Michael D
- Van Nostrand, Douglas
- Wartofsky, Leonard
Year: 2013
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
- Washington Cancer Institute
Department: - Medicine/Nuclear Medicine
All authors: - Khorjekar G, Senthamizhchelvan S, Hobbs R, Orquiza M, Atkins F, Mete M, Garcia C, Wartofsky L, Sgouros G, Van Nostrand D
|